BG Medicine, Inc.
| Nasdaq: BGMD
BG Medicine, Inc. is a life sciences company, which is focused on the discovery, development and commercialization of novel cardiovascular diagnostics to address significant unmet medical needs, improve patient outcomes and contain healthcare costs. The company is commercializing two diagnostic tests, which are marketed under the brand names BGM Galectin-3 and CardioSCORE. BG Medicine was founded by Noubar B. Afeyan on February 9, 2000 and is headquartered in Waltham, MA.